0001179110-17-008065.txt : 20170526
0001179110-17-008065.hdr.sgml : 20170526
20170526151052
ACCESSION NUMBER: 0001179110-17-008065
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170525
FILED AS OF DATE: 20170526
DATE AS OF CHANGE: 20170526
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EnteroMedics Inc
CENTRAL INDEX KEY: 0001371217
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2800 Patton Rd
CITY: St Paul
STATE: MN
ZIP: 55113
MAIL ADDRESS:
STREET 1: 2800 Patton Rd
CITY: St Paul
STATE: MN
ZIP: 55113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDFISCHER CARL
CENTRAL INDEX KEY: 0001110780
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33818
FILM NUMBER: 17873660
MAIL ADDRESS:
STREET 1: 161 WEST 61ST STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
edgar.xml
FORM 4 -
X0306
4
2017-05-25
0
0001371217
EnteroMedics Inc
ETRM
0001110780
GOLDFISCHER CARL
2800 PATTON ROAD
ST. PAUL
MN
55113
1
0
0
0
Common Stock
2017-05-25
4
S
0
4571
4.85
A
0
I
See footnote (1)
Common Stock
2017-05-25
4
S
0
97
4.85
A
0
I
See footnote note (2)
Director Option (Right to Buy)
50410.5
2008-03-25
2018-03-24
Common Stock
3
3
D
Director Option (Right to Buy)
12159
2009-05-05
2019-05-05
Common Stock
1
1
D
Director Option (Right to Buy)
2646
2010-05-06
2020-05-06
Common Stock
1
1
D
Director Option (Right to Buy)
2761.5
2011-05-05
2021-05-05
Common Stock
9
9
D
Director Option (Right to Buy)
2908.5
2012-05-09
2022-05-09
Common Stock
9
9
D
Director Option (Right to Buy)
924
2013-05-08
2023-05-08
Common Stock
9
9
D
Director Option (Right to Buy)
1932
2014-05-07
2024-05-07
Common Stock
23
23
D
Director Option (Right to Buy)
1176
2015-05-06
2025-05-06
Common Stock
23
23
D
Director Option (Right to Buy)
1176
2015-06-06
2025-05-06
Common Stock
23
23
D
Director Option (Right to Buy)
52.50
2016-05-04
2026-05-04
Common Stock
42
42
D
Director Option (Right to Buy)
7.12
2017-02-08
2027-02-08
Common Stock
35000
35000
D
Represents shares held by Bay City Capital Fund IV, L.P. ("Fund IV"), including the shares held by Dr. Goldfischer; and indirect interests of Bay City Capital LLC ("BCC"), the manager of Bay City Capital Management IV LLC ("Management IV"), and Management IV, the general partner of Fund IV. Dr. Goldfischer is Managing Director of BCC. Dr. Goldfischer, BCC and Management IV each disclaims beneficial ownership in such shares, except to the extent of their pecuniary interest therein.
Represents shares held by Bay City Capital Fund IV Co-Investment Fund, L.P. ("Co-Investment IV"), including the shares held by Dr. Goldfischer; and indirect interests of BCC, the manager of Management IV, and Management IV, the general partner of Co-Investment IV. Dr. Goldfischer, BCC and Management IV each disclaims beneficial ownership in such shares, except to the extent of their pecuniary interest therein.
25% of the shares shall vest immediately, and the remaining shares shall vest 1/36 per month thereafter, as long as the reporting person remains a director of the company.
25% of the shares subject to the option are exercisable immediately. The remaining 75% of the shares subject to the option shall vest in a series of thirty-six (36) successive equal monthly installments upon completion of each month over the three (3) year period measured from the date shown.
Option vests in successive installments of 1/12th per month beginning the date shown.
The price reported is the weighted average sale price for the transactions reported. The prices received ranged from $4.75 to $5.00. The Reporting Person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range.
Carl Goldfischer by Scott P. Youngstrom, Attorney in Fact
2017-05-26